Skip to main content.

Getting Started

 

If your research involves human subjects or is regulated by the Food and Drug Administration (FDA), it requires review and approval from an institutional review board (IRB). Start by answering these questions:

  1. Is it human subjects research?
    • Is your project a systematic investigation designed to produce generalizable knowledge?
    • Will your research collect information or specimens from living individuals through interaction or interventions?
    • Will you collect, use, analyze, or create identifiable information or biospecimens about living individuals?
  2. Is it research involving the FDA?
    • Does the research involve the study of a drug, biologic, or device regulated by the FDA?
    • Will research data be reported to the FDA?
  3. Our Decision Tree guides you through a determination of whether IRB review is required and, if so, which type of application form most likely fits your project. This Decision Tree video will walk you through completing the Decision Tree.

If you answered yes to 1 or 2 above, then your study requires IRB review and approval.

If neither 1 or 2 apply to your project, please consider whether your project might qualify as Not Human Subjects Research or Quality Improvement. You may contact the IRB office for additional guidance.

At KU Medical Center there are five IRB review and application types:

  • Flexible IRB Review

    Projects that are minimal risk and are not associated with federal funding or support may qualify for Flexible IRB Review. Examples include behavioral interventions or minimal-risk biomedical procedures. Flexible IRB review allows abbreviated IRB applications and consent forms, streamlined review by IRB Chair or staff members and elimination of the continuing review requirement. Visit Flexible IRB Review for more detailed information.

  • Secondary Research

    Secondary research involves the analysis of data or specimens that have been or will be collected for non-research purposes. Secondary research may also include analysis of data or specimens that were collected under other research protocols. Examples include chart reviews, use of existing specimen repositories, and big data research.

  • Exempt Research

    Exempt research involves low-risk studies, federally funded or supported, that meet criteria specified by federal regulations. Examples include online surveys, interviews and focus groups, and research on education or curricula.

  • Expedited Research

    Expedited research includes studies, federally funded or supported, that meet specific categories in the federal regulations and involve no greater than minimal risk. Expedited review procedures allow the IRB to review without convening a full IRB meeting. Examples include analysis of non-invasive collection of biospecimens, MRI studies, creating a data registry or repository for future studies, or minimal risk behavioral interventions.

  • Full-Board Review

    Full-board studies are those that do not qualify for any of four categories above. These studies are reviewed at convened board meetings. KU Medical Center IRB meetings occur six times monthly.

Two charts provide additional help to select the appropriate application form:

  • Submission requirements are tailored to the type of IRB submission. Users will answer basic questions on the 'Smart Tabs' of the electronic application and upload key documents into the relevant tabs. The list of Documents to Prepare (PDF) guides the study team about which items should be uploaded into eCompliance.
  • Please find more information on the how to submit a new study page.

All KU Medical Center and KULC faculty may exercise the privilege of being named as principal investigator (PI) or project director on proposals. University or hospital staff may qualify to serve as PI when approved by the appropriate chair, dean, center director or hospital administrator. Qualifications for PIs are determined by the HRPP in consultation with institutional leaders.

Faculty members from affiliated institutions may be approved to serve as PI for a KU Medical Center project on a case-by-case basis.

For more detailed information about PI responsibilities visit IRB SOP 18.0.

All KU Medical Center research personnel, KU Medical Center staff, affiliated staff and collaborators from other institutions who participate in human subjects research at KU Medical Center must pass and maintain current Human Research Protection training. KU Medical Center partners with CITI (Collaborative Institutional Training Initiative) to provide Human Research Protection training. Training must be renewed every three years.

Research personnel should complete either the CITI Biomedical Researchers Basic Course or the CITI Social-Behavioral Researchers Basic Course, depending on the type of research activity planned. Advanced courses may be required if research involves vulnerable populations. For research personnel who previously completed Social-Behavioral training and are now involved in biomedical research, an additional course "FDA Research for Social-Behavioral Investigators" will satisfy this requirement.

The CITI system also is used for training in Good Clinical Practice (GCP) and Responsible Conduct of Research (RCR), if applicable. However, GCP and RCR training are separate requirements and cannot be substituted for the Human Research Protections requirement.

Detailed information on how to access, complete and verify training can be found in the CITI Guide to Getting Started (PDF). While it is important to complete your CITI training for Human Research Protection and Conflict of Interest in a timely manner, we ask that you wait until you have access to eCompliance before you log into CITI. Once you are able to log into eCompliance, you can log into CITI and click on the LOG IN THROUGH MY INSTITUTION link.

Research proposals are submitted through our electronic IRB system called myIRB. myIRB houses all IRB review activities and serves as the official source for all IRB-approved documentation.

Accessing myIRB

  • myIRB is part of the myResearch suite. KU Medical Center personnel access the system using KU Medical Center single sign on. 
  • For individuals affiliated with KU Medical Center research, but not an employee or student at the University, please contact your Principal Investigator (PI). The Account Requestor list will help the PI identify your contact to request an account.

myIRB Guidance

Detailed instructions on how to prepare documents, access, navigate and submit within the myIRB system are available in the myIRB Guidance Document and on the myIRB intranet page. Departmental training and myIRB assistance can be arranged by contacting the IRB Office. Support for myResearch is provided by the myResearchSupport team.

The Health Insurance Portability and Accountability Act of 1996 (HIPAA) is a federal law that provides safeguards that protect patient privacy. HIPAA requirements are tailored to the type of research and may affect data collection, data sharing, recruitment, informed consent, and collaborations with external entities.

Visit the KU Medical Center Privacy Program for more detailed instructions.

Yes. KU Medical Center has multiple relationships with external IRBs including commercial IRBs and IRBs at other academic institutions through the SMART IRB network. There are special application forms and consent form templates when using external IRBs. Visit KU Medical Center IRB Reliance Resources for additional information about the types of IRB reliance and how to request use of external IRBs.

  • The PI must submit the initial submission and all major updates and modifications. A PI Proxy can submit minor updates such as study team updates and responses to minor provisos. Full details are provided in the PI Proxy section of the myIRB Guidance Document. Send Proxy Change Requests to IRBHelp@kumc.edu.
  • Ensure the team member list is up-to-date and all have current conflic of interest disclosures.
  • Only study team modifications can be attached to Continuing Reviews; all other types of modifications to the study must be submitted separately.
  • Use the most recent Continuing Review Supplement Form from the IRB Forms list.
  • The PI must submit the Contining Review; Proxy can submit subsequent responses to clarifications.
  • IRB Guidance has more information on specific types of research and review.
  • Please see our Tutorials and Resources page for more assistance.
  • For specific questions related to your submission, please contact the IRB Coordinator listed in myIRB. Please note that due to the system notification protocols, comments left in myIRB may not be seen by IRB staff unless the "Notify IRB Staff" is selected in the comment form.
  • Requests to change PI Proxy, add funding sources, or other general questions can be sent to IRBHelp@kumc.edu.
Research Administration

University of Kansas Medical Center
Research Administration
Mailstop 1039
3901 Rainbow Boulevard
Kansas City, KS 66160
Office Location: Support Services Building, Suite 120
Phone: 913-588-1261
Fax: 866-255-2129
Email: researchadministration@kumc.edu